[go: up one dir, main page]

WO2011152689A3 - Method for purifying fucoxanthin derived from seaweed - Google Patents

Method for purifying fucoxanthin derived from seaweed Download PDF

Info

Publication number
WO2011152689A3
WO2011152689A3 PCT/KR2011/004103 KR2011004103W WO2011152689A3 WO 2011152689 A3 WO2011152689 A3 WO 2011152689A3 KR 2011004103 W KR2011004103 W KR 2011004103W WO 2011152689 A3 WO2011152689 A3 WO 2011152689A3
Authority
WO
WIPO (PCT)
Prior art keywords
seaweed
fucoxanthin
derived
purifying fucoxanthin
purifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/004103
Other languages
French (fr)
Korean (ko)
Other versions
WO2011152689A2 (en
WO2011152689A9 (en
Inventor
황영재
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESTORE LABS CO Ltd
Original Assignee
RESTORE LABS CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RESTORE LABS CO Ltd filed Critical RESTORE LABS CO Ltd
Priority claimed from KR1020110053920A external-priority patent/KR20110133000A/en
Publication of WO2011152689A2 publication Critical patent/WO2011152689A2/en
Publication of WO2011152689A9 publication Critical patent/WO2011152689A9/en
Publication of WO2011152689A3 publication Critical patent/WO2011152689A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to a method for providing more stabilized fucoxanthin by using vitamin C, which is a water-soluble antioxidizing agent, in the step of extracting fucoxanthin from brown alga. According to the present invention, fucoxanthin is more stabilized, and thus the problem of the deterioration of yield with time is improved.
PCT/KR2011/004103 2010-06-03 2011-06-03 Method for purifying fucoxanthin derived from seaweed Ceased WO2011152689A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0052513 2010-06-03
KR20100052513 2010-06-03
KR1020110053920A KR20110133000A (en) 2010-06-03 2011-06-03 Purification method of fucoxanthin derived from seaweed
KR10-2011-0053920 2011-06-03

Publications (3)

Publication Number Publication Date
WO2011152689A2 WO2011152689A2 (en) 2011-12-08
WO2011152689A9 WO2011152689A9 (en) 2012-01-26
WO2011152689A3 true WO2011152689A3 (en) 2012-04-19

Family

ID=45067210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/004103 Ceased WO2011152689A2 (en) 2010-06-03 2011-06-03 Method for purifying fucoxanthin derived from seaweed

Country Status (1)

Country Link
WO (1) WO2011152689A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105997957A (en) * 2016-07-08 2016-10-12 韩春超 Fucoxanthine hydrogel patch for preventing and treating obesity

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050039283A (en) * 2003-10-24 2005-04-29 목도창조 주식회사 Extracting method of fucoxanthin using brown algae
EP1884238A1 (en) * 2005-05-24 2008-02-06 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
US20080206275A1 (en) * 2006-12-08 2008-08-28 Zakir Ramazanov Composition for treating obesity and method of using the same
US20080233209A1 (en) * 2007-03-22 2008-09-25 Polifenoles Naturales, Sl Composition and method of use for the treatment of metabolic syndrome and inflammation
JP2008280281A (en) * 2007-05-10 2008-11-20 Hokkaido Univ Anti-obesity active agent
WO2009048249A2 (en) * 2007-10-10 2009-04-16 Amicogen, Inc. Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050039283A (en) * 2003-10-24 2005-04-29 목도창조 주식회사 Extracting method of fucoxanthin using brown algae
EP1884238A1 (en) * 2005-05-24 2008-02-06 National University Corporation Hokkaido University Agent having antiobesity activity and method of inhibiting obesity
US20080206275A1 (en) * 2006-12-08 2008-08-28 Zakir Ramazanov Composition for treating obesity and method of using the same
US20080233209A1 (en) * 2007-03-22 2008-09-25 Polifenoles Naturales, Sl Composition and method of use for the treatment of metabolic syndrome and inflammation
JP2008280281A (en) * 2007-05-10 2008-11-20 Hokkaido Univ Anti-obesity active agent
WO2009048249A2 (en) * 2007-10-10 2009-04-16 Amicogen, Inc. Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
H. MAEDA ET AL.: "Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCPI expression in white adipose tissues", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 332, 2005, pages 392 - 397 *
K. KANAZAWA ET AL.: "Commercial-scale preparation ofbiofunctional fucoxanthin from waste parts of brown sea algae Laminaliajaponica", FOOD SCIENCE AND TECHNOLOGY RESEARCH, vol. 14, no. 6, 2008, pages 573 - 582 *
M. WRONA ET AL.: "Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids", FEE RADICAL BIOLOGY & MEDICINE, vol. 36, no. 9, 2004, pages 1094 - 1101 *

Also Published As

Publication number Publication date
WO2011152689A2 (en) 2011-12-08
WO2011152689A9 (en) 2012-01-26

Similar Documents

Publication Publication Date Title
WO2012159051A3 (en) Chemically modified graphene
WO2012018881A3 (en) Methods and compositions for the regulation of rna
WO2012040209A3 (en) Machine-readable symbols
WO2011116252A3 (en) Method and system for processing of aquatic species
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
WO2014036219A3 (en) Methods and compositions for treatment of a genetic condition
WO2010114982A3 (en) Lyophilization cakes of proteasome inhibitors
WO2014015256A3 (en) Enzymatic oxidation of 5-hydroxymethylfurfural and derivatives thereof
WO2012129341A3 (en) Disease detection in plants
WO2014015210A3 (en) Microorganisms and processes for the conversion of glycerol to isoprene
WO2014100799A3 (en) Cyanobacterium sp. for production of compounds
WO2011098979A3 (en) Radioresistant alga of the coccomyxa genus
WO2012126123A8 (en) Method of recovering plant-derived proteins
EP2548986A4 (en) Steel for nitrocarburization, nitrocarburized components, and production method for same
WO2012177129A3 (en) Valencene synthase
WO2012081851A3 (en) Novel strain of lentinus edodes gna01
WO2012135286A3 (en) Stabilized acid amplifiers
PL2545019T3 (en) Method for distillative extraction of pure 1,3-butadiene from raw 1,3-butadiene
WO2013040062A3 (en) Characterizing multiple sclerosis
WO2011095571A3 (en) Method for producing astaxanthin dimethyl disuccinate
WO2010099230A3 (en) Separation of pyrophosphate release and pyrophosphate detection
WO2012074855A3 (en) Methods of identifying a cellular nascent rna transcript
NZ614634A (en) Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
WO2012112156A3 (en) Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof
WO2012078586A3 (en) Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11790047

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11790047

Country of ref document: EP

Kind code of ref document: A2